Humphreys JE et al. |
A clarithromycin sensitivity survey in the United Kingdom using Stokes' method. |
1993 |
J. Antimicrob. Chemother. |
pmid:8226438
|
Scaglione F et al. |
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients. |
1993 |
J Chemother |
pmid:8229150
|
Dautzenberg B et al. |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. |
1993 |
Arch. Intern. Med. |
pmid:8427539
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Scaglione F et al. |
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. |
1993 |
J. Antimicrob. Chemother. |
pmid:8262876
|
Guay DR and Craft JC |
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295810
|
Hebert AA et al. |
Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295811
|
Pukander JS et al. |
Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295812
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Lederer J et al. |
Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8414785
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
de Vega T et al. |
Clarithromycin-induced leukocytoclastic vasculitis. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8404922
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|